Edition:
United States

Reckitt Benckiser Group PLC (RB.L)

RB.L on London Stock Exchange

6,526.00GBp
14 Jun 2019
Change (% chg)

-83.00 (-1.26%)
Prev Close
6,609.00
Open
6,609.00
Day's High
6,622.00
Day's Low
6,445.00
Volume
1,892,011
Avg. Vol
1,447,910
52-wk High
7,174.00
52-wk Low
5,559.00

Latest Key Developments (Source: Significant Developments)

Reckitt Chairman says CEO search "well underway"
Thursday, 9 May 2019 06:34am EDT 

May 9 (Reuters) - Reckitt Benckiser Group PLC ::RECKITT BENCKISER CHAIRMAN SAYS COMPANY CONTINUES TO ACTIVELY PURSUE M&A OPPORTUNITIES - AGM.RECKITT BENCKISER CHAIRMAN SAYS COMPANY IS "WELL UNDERWAY" WITH COMPREHENSIVE PROCESS TO SELECT CEO SUCCESSOR.RECKITT BENCKISER CHAIRMAN SAYS HOPEFUL COMPANY WILL BE ABLE TO NAME CEO SUCCESSOR IN "NOT TOO DISTANT FUTURE".  Full Article

Reckitt Benckiser Sees Improving Growth In Remainder Of Year After Slow Q1
Thursday, 2 May 2019 02:00am EDT 

May 2 (Reuters) - Reckitt Benckiser Group PLC ::Q1 TOTAL SALES 3,157 MILLION STG VERSUS 3,111 MILLION STG AS REPORTED A YEAR EARLIER.RB2.0 REMAINS ON TRACK..REMAIN ON TRACK FOR FULL YEAR NET REVENUE TARGET OF +3-4% LFL WITH GROWTH TO BE H2 WEIGHTED..EXPECT TO SEE IMPROVING GROWTH IN REMAINDER OF YEAR, PARTICULARLY IN H2.REITERATE 2019 TARGETS OF +3-4% LFL NET REVENUE GROWTH AND ADJUSTED(1) OPERATING MARGIN TO BE MAINTAINED.RECKITT BENCKISER, ON INDIVIOR/RB PHARMA-RELATED MATTERS, SAYS REMAINS INVOLVED IN ONGOING INVESTIGATIONS BY US DOJ, US FEDERAL TRADE COMMISSION.MAY INCUR LIABILITIES IN RELATION TO MATTERS RELATING TO INDIVIOR / RB PHARMA-RELATED LITIGATION MATTERS.ONGOING INVESTIGATIONS REFERS TO MATTERS RELATING TO RB PHARMACEUTICALS BUSINESS PRIOR TO ITS DEMERGER IN DECEMBER 2014 TO FORM INDIVIOR.FINAL COST ON RESOLVING INDIVIOR / RB PHARMA-RELATED LITIGATION MATTERS MAY BE SUBSTANTIALLY HIGHER THAN THIS PROVISION.  Full Article

Clorox Files False-Advertising Lawsuit Against The Maker Of Lysol
Wednesday, 20 Mar 2019 06:14pm EDT 

Clorox Co ::CLOROX FILES FALSE-ADVERTISING LAWSUIT AGAINST THE MAKER OF LYSOL.CLOROX - FILED LAWSUIT AGAINST RECKITT BENCKISER IN RESPONSE TO A WIDE-RANGING ADVERTISING CAMPAIGN FOR RB'S LYSOL BRAND.CLOROX - ACCORDING TO LAWSUIT, RECKITT BENCKISER'S CAMPAIGN IS DESIGNED TO "MISLEAD CONSUMERS TO PURCHASE" RECKITT'S PRODUCTS INSTEAD OF CO'S PRODUCTS.  Full Article

Petiq, Inc. Appoints Animal Health Executive Susan Sholtis As President
Wednesday, 19 Sep 2018 08:00am EDT 

Sept 19 (Reuters) - PetIQ Inc ::PETIQ, INC. APPOINTS PROVEN MULTINATIONAL ANIMAL HEALTH EXECUTIVE SUSAN SHOLTIS AS PRESIDENT.PETIQ INC - APPOINTED SUSAN SHOLTIS AS PRESIDENT, EFFECTIVE OCTOBER 1, 2018.PETIQ INC - SHOLTIS WILL SIMULTANEOUSLY RESIGN FROM HER DUTIES AS A MEMBER ON COMPANY'S BOARD.PETIQ INC - SHOLTIS HAS SERVED AS A GLOBAL MARKETING HEAD IN HEALTH DIVISION AT RECKITT BENCKISER SINCE 2017.  Full Article

Jab Holdings Cuts Stake To 2.97 Pct In Reckitt Benckiser
Wednesday, 8 Aug 2018 09:32am EDT 

Aug 8 (Reuters) - Reckitt Benckiser Group PLC ::JAB HOLDINGS B.V. CUTS STAKE TO 2.97 PERCENT FROM 3.68 PERCENT IN RECKITT BENCKISER GROUP PLC - FILING.  Full Article

Reckitt CEO bullish on consumer health, no comment on Pfizer
Monday, 19 Feb 2018 02:38am EST 

Feb 19 (Reuters) - Reckitt Benckiser Group Plc ::RECKITT BENCKISER CEO SAYS NO COMMENT ON PFIZER CONSUMER HEALTH AUCTION.RECKITT BENCKISER CEO SAYS ACQUISITIONS MUST BE STRATEGICALLY COMPELLING, RB MUST BE A BETTER OWNER, AND MUST DRIVE VALUE FOR SHAREHOLDERS.RECKITT BENCKISER CEO SAYS CONFIDENT ABOUT GROWTH OF CONSUMER HEALTH CATEGORY IN LONG TERM.  Full Article

Reckitt Benckiser Says Targeting 13-14 Pct Total Revenue Growth For 2018 ​
Monday, 19 Feb 2018 02:00am EST 

Feb 19 (Reuters) - Reckitt Benckiser Group Plc ::FINAL DIVIDEND 97.7 PENCE PER SHARE.FY ADJUSTED DILUTED EPS ROSE 10 PERCENT TO 316.9 PENCE.FY ‍TOTAL OPERATIONS (INCLUDING DISCONTINUED OPERATIONS) ADJ DILUTED EPS OF 324.6 PENCE ​.TOTAL DIVIDEND 164.3 PENCE PER SHARE.FY REVENUE 11.51 BILLION STG.Q4 NET REVENUE ‍3,289 MILLION POUNDS, +25%​.‍+2% LIKE-FOR-LIKE NET REVENUE GROWTH IN Q4​.‍FY FLAT LFL NET REVENUE IN LINE WITH GUIDANCE​.‍FY TOTAL GROUP ADJUSTED OPERATING MARGIN OF -70BPS TO 27.1%​.FY ADJUSTED NET INCOME ‍2,253 MILLION POUNDS, +10%​.‍FY REPORTED DILUTED EPS OF 867.9P​.‍FREE CASH FLOW GENERATION OF £2,129M IN FY ​.‍FOR 2018 TARGETING +13-14% TOTAL REVENUE GROWTH​."‍WHILST 2018 WILL SEE SOME SPECIFIC FACTORS IMPACTING MARGIN, REITERATE MEDIUM-TERM TARGET OF MODERATE OPERATING MARGIN EXPANSION​".ON ‍MJN COST SYNERGIES, EXPECTING TO ACHIEVE IN REGION OF $300M IN ANNUAL COST SAVINGS BY END OF THIRD FULL YEAR OF OWNERSHIP.‍FOR 2018, EXPECT MJN COST SYNERGIES TO SLIGHTLY EXCEED ADDITIONAL INFRASTRUCTURE COSTS ASSOCIATED WITH NEW BUS​.  Full Article

Reckitt Benckiser CEO comments
Wednesday, 18 Oct 2017 02:58am EDT 

Oct 18 (Reuters) - Reckitt Benckiser Group Plc :Reckitt benckiser ceo says seeing subdued growth in developed and developing markets.Reckitt benckiser ceo says health unit to have sales of around 7.5 billion pounds, with hygiene/home sales around 5 billion.Reckitt benckiser ceo says too early to discuss 2018 forecast.Reckitt benckiser ceo says both business units to have marketing directors and has announced executive line-up.  Full Article

JAB Holdings discloses 6.69 pct stake in Reckitt Benckiser - filing
Tuesday, 3 Oct 2017 04:50am EDT 

Oct 3 (Reuters) - Regulatory Filing::JAB HOLDINGS B.V. DISCLOSES 6.69 PERCENT STAKE IN RECKITT BENCKISER GROUP PLC - REGULATORY FILING.  Full Article

Reckitt Benckiser names Christopher Sinclair as next chairman
Tuesday, 19 Sep 2017 02:00am EDT 

Sept 19 (Reuters) - Reckitt Benckiser Group Plc ::ADRIAN BELLAMY HAS DECIDED TO RETIRE AS NON-EXECUTIVE CHAIRMAN EFFECTIVE FROM 2018 ANNUAL GENERAL MEETING.ADRIAN BELLAMY WILL ALSO RETIRE FROM BOARD.CHRISTOPHER SINCLAIR, WHO HAS SERVED ON BOARD SINCE 2015, WILL TAKE ON ROLE OF NON- EXECUTIVE CHAIRMAN AT THAT TIME.  Full Article

Photo

Reckitt picks PepsiCo executive as CEO, going outside for first time

Consumer goods group Reckitt Benckiser has picked PepsiCo executive Laxman Narasimhan as its next chief executive, becoming the latest industry heavyweight to turn to a company outsider to tackle faltering growth and new media-savvy rivals.